AIDSMALIGNANCY CONSORTIUM: advancing care and prevention for people with HIV-related cancers
Official title: Consortium for Advancing Management and Prevention of Cancer in People with HIV
Funded at Icahn School of Medicine at Mount Sinai · NIH-11535249 · Data updated 2026-11-12
A long-running NIH program tests new cancer treatments and prevention strategies for people living with HIV to reduce cancer in this population.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | August 29, 2006 |
| Project end | August 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $31,044 |
| NIH project number | 3UM1CA121947-20S1 |
| Project ID | NIH-11535249 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults living with HIV who develop cancer or precancerous conditions, treated at AMC-affiliated sites.
✕Less likely to help
This program may not directly benefit individuals without HIV-related cancer or those who do not meet trial criteria.
What this research studies
This program conducts clinical trials to find better ways to treat and prevent cancers that occur more often in people with HIV. It includes a wide network of trial sites worldwide and a strong focus on translating trial results into real-world care guidelines. Participants would contribute if they have HIV-associated cancer or pre-cancer conditions and meet site criteria. The effort also studies the biology of these cancers to identify new targets for therapy. It has a track record of mentoring researchers and engaging people living with HIV and cancer survivors in planning.
Why it matters
Potential benefit: If successful, patients with HIV-related cancers could receive more effective treatments and improved guidelines for prevention and care.
How similar studies have gone: AMC has already initiated many interventional trials, published extensively, and influenced guidelines in HIV-related cancer care.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Sparano, Joseph a. — Icahn School of Medicine at Mount Sinai
- Study coordinator: Sparano, Joseph a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.